Mice lacking hepatic lipase are lean and protected against
diet-induced obesity and hepatic steatosis.
Endocrinology
, 2010 Mar: 993-1001
Level of macrophage uPA expression is an important
determinant of atherosclerotic lesion growth in Apoe-/-
mice.
Arteriosclerosis, thrombosis, and vascular
biology
, 2009 Nov: 1737-44
TGF-[beta]1 limits plaque growth, stabilizes plaque
structure, and prevents aortic dilation in apolipoprotein E-null
mice.
Arteriosclerosis, thrombosis, and vascular
biology
, 2009 Sep: 1251-7
Energy balance in congenital generalized lipodystrophy
type I.
Metabolism: clinical and
experimental
, 2008 Aug: 1155-61
Hormonal regulation of testicular steroid and cholesterol
homeostasis.
Molecular endocrinology (Baltimore,
Md.)
, 2008 Mar: 623-35
Reduced atherosclerosis in chow-fed mice expressing high
levels of a catalytically inactive human hepatic lipase.
Atherosclerosis
, 2007 Nov: 66-74
Attenuated corticosterone response to chronic ACTH
stimulation in hepatic lipase-deficient mice: evidence for a role
for hepatic lipase in adrenal physiology.
American journal of physiology. Endocrinology
and metabolism
, 2006 May: E908-15
Divergent effects of the catalytic and bridging functions
of hepatic lipase on atherosclerosis.
Arteriosclerosis, thrombosis, and vascular
biology
, 2004 Sep: 1696-702
Macrophage-targeted overexpression of urokinase causes
accelerated atherosclerosis, coronary artery occlusions, and
premature death.
Circulation
, 2004 May 4: 2129-35
The bridging function of hepatic lipase clears plasma
cholesterol in LDL receptor-deficient
"apoB-48-only" and
"apoB-100-only" mice.
Journal of lipid research
, 2004 Mar: 551-60
Molecular cloning of nonsecreted endothelial cell-derived
lipase isoforms.
Genomics
, 2004 Jan: 24-33